Rhumbline Advisers Applied Molecular Transport Inc. Transaction History

Rhumbline Advisers

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.76 - $7.65 $67,164 - $186,162	-24,335 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$5.63 - $13.88 $8,540 - $21,055	1,517 Added 6.65%	24,335 $183,000
Q4 2021 Feb 10, 2022	SELL	$13.23 - $26.05 $5,728 - $11,279	-433 Reduced 1.86%	22,818 $319,000
Q3 2021 Nov 12, 2021	BUY	$25.87 - $46.61 $28,974 - $52,203	1,120 Added 5.06%	23,251 $602,000
Q2 2021 Aug 05, 2021	SELL	$39.76 - $64.31 $61,866 - $100,066	-1,556 Reduced 6.57%	22,131 $1.01 Million
Q1 2021 May 06, 2021	BUY	$30.5 - $74.14 $308,629 - $750,222	10,119 Added 74.58%	23,687 $1.04 Million
Q4 2020 Feb 10, 2021	BUY	$29.39 - $35.0 $58,985 - $70,245	2,007 Added 17.36%	13,568 $417,000
Q3 2020 Nov 12, 2020	BUY	$20.49 - $33.58 $236,884 - $388,218	11,561 New	11,561 $368,000

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.